title: Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.
authors.affiliation: Photodermatosis Clinic and Laser Unit, Department of Dermatology, Rabin Medical Center, Petah-Tikva, Israel. docalevi@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Levi
authors.affiliation: Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
authors.forename: Y
authors.initials: Y
authors.lastname: Tal
authors.affiliation: Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
authors.forename: Z
authors.initials: Z
authors.lastname: Dranitzki
authors.affiliation: Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
authors.forename: M
authors.initials: M
authors.lastname: Shalit
authors.affiliation: Department of Dermatology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
authors.forename: C D
authors.initials: CD
authors.lastname: Enk
mesh_terms: D002648:Child; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D000069444:Omalizumab / Q000009:adverse effects / Q000627:therapeutic use*; D010787:Photosensitivity Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D012720:Severity of Illness Index; D013472:Sunlight / Q000009:adverse effects*; D016896:Treatment Outcome; D014581:Urticaria / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D007155:Immunologic Factors; D000069444:Omalizumab